Curcuma longa (turmeric) based herbal compound formulations as dietary supplements

Patent metadata

Field	Value
Publication number	US-9833491-B2
Application number	US-38317509-A
Country	US
Kind code	B2
Filing date	Mar 20, 2009
Priority date	Apr 7, 2008
Publication date	Dec 5, 2017
Grant date	Dec 5, 2017

Abstract

Herbal compound formulations using herbs curcuma longa (turmeric), ocimum sanctum (holy basil) and emblica officinalis (amla) in their natural forms and a method of packaging the same for dietary supplement as tablets, wafers, capsules and as teabags where the packaging of individual dosages and the outer packaging may use visual display of color that represents the proportion and presence of different herbs in the herbal compound.

First claim

What is claimed is:

1. An herbal formulation for reducing cholesterol, blood glucose, and stress hormone levels, the herbal formulation comprising:
a proportion of Ocimum sanctum herb; a proportion of Emblica officinalis herb; and a proportion of Curcuma longa herb, wherein the Ocimum sanctum, Emblica and Curcuma longa are only active herbal ingredients in the herbal formulation and the herbal formulation is formulated as a dietary supplement for human consumption;
the proportion of Ocimum sanctum herb, by weight is not below 9.5% and not greater than 25.5%; the proportion of Emblica officinalis herb, by weight is not below 19.5%, and not greater than 35.5%; and the proportion of Curcuma longa herb, by weight is not below 49.5% and not greater than 70.5% in the herbal formulation, wherein the herbal formulation is contained within a packaged individual dosage form, and wherein the dosage form is selected from the group consisting of a liquid dissolvable wafer, a swallow-able wafer, a capsule, a tea bag formulation, and a tablet.

2. The herbal formulation as in claim 1 , wherein the formulation further comprises a binding agent selected from a non-animal and/or a natural vegetarian source.

3. The herbal formulation as in claim 1 wherein the formulation further comprises a flavoring agent from one of, cinnamon, cardamom, and peppermint.

4. The herbal formulation as in claim 1 , wherein the individual dosage form comprises 375 mg. to 8.00 gram of said herbal formulation.

5. The herbal formulation as in claim 1 , wherein the packaged dosage form further comprises a visual display showing the proportions of the Ocimum sanctum herb, the Emblica officinalis herb and the Curcuma longa herb on the packaged dosage form.

6. The herbal formulation as in claim 5 , wherein the visual display shows the colors of the Curcuma longa herb, Ocimum sanctum herb, and the Emblica officinalis herb as substantially yellow, light green and dark green, respectively.

7. A method of formulating an herbal formulation for reducing cholesterol, blood glucose, and stress hormone levels, the method comprising the steps of:
formulating an herbal formulation consisting of a proportion of Ocimum sanctum herb; a proportion of Emblica officinalis herb; and a proportion of Curcuma longa herb;
wherein the proportion of Ocimum sanctum herb, by weight is not below 9.5% and not greater than 25.5%; the proportion of Emblica officinalis herb, by weight is not below 19.5%, and not greater than 35.5%; and the proportion of Curcuma longa herb, by weight is not below 49.5% and not greater than 70.5% in the herbal formulation;
packaging the formulation within an individual dose, wherein the individual dosage form selected from the group consisting of, a liquid dissolvable wafer, a swallow-able wafer, a capsule, a tea bag formulation, and a tablet.

8. The method of formulating an herbal formulation as in claim 7 , further comprising the steps of:
adding a binding agent selected from a non-animal and/or a natural vegetarian source to the formulation.

9. The method of formulating an herbal formulation as in claim 7 further comprises the steps of:
adding a flavoring agent selected from one of, cinnamon, cardamom, and peppermint to the formulation.

10. The method of formulating an herbal formulation as in claim 7 ,
wherein the individual dosage form comprises 375 mg. to 8.00 gram of said herbal formulation.

11. The method of formulating an herbal formulation as in claim 7 , further comprises the steps of:
putting a visual display showing the proportions of the Ocimum sanctum herb, the Emblica officinalis herb and the Curcuma longa herb on the packaged dosage form.

12. The method of formulating an herbal formulation as in claim 7 further comprising the steps of:
putting a visual colored display on the packaged dosage form showing the colors of the Curcuma longa herb, Ocimum sanctum herb, and the Emblica officinalis herb as substantially yellow, light green and dark green, respectively.

Assignees

• Singhal Tara Chand

Inventors

• Singhal Tara Chand

Classifications

• A61K36/9066 Primary

  Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger · CPC title

• A61K36/53

  Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender · CPC title

• A61K36/47

  Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean) · CPC title

• A61P39/00

  General protective or antinoxious agents · CPC title